This brand name is authorized in Ecuador
The drug CAPROCAT contains one active pharmaceutical ingredient (API):
|
1
Aminocaproic acid
UNII U6F3787206 - AMINOCAPROIC ACID
|
|
Aminocaproic acid is 6-aminohexanoic acid, which acts as an inhibitor of fibrinolysis. The fibrinolysis-inhibitory effects of aminocaproic acid appear to be exerted principally via inhibition of plasminogen activators and to a lesser degree through antiplasmin activity. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B02AA01 | Aminocaproic acid | B Blood and blood forming organs → B02 Antihemorrhagics → B02A Antifibrinolytics → B02AA Amino acids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 5395-MEE-0820 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
